 |
Scottish
Public Health Observatory – Diabetes update |
| |
Diabetes
Mortality Data - - Diabetes Secondary Care Data (ScotPHO) |
| |
|
|
The
association between symptomatic, severe hypoglycaemia and mortality
in type 2 diabetes: retrospective epidemiological analysis of
the ACCORD study |
| |
Symptomatic, severe hypoglycaemia does not appear
to account for the difference in mortality between the two study
arms up to the time when the ACCORD intensive glycaemia arm was
discontinued (BMJ) |
| |
|
|
Diabetes
sugar 'can go too low' |
| |
Cardiff researchers looked at nearly 50,000
patients with type 2 diabetes and found the lowest glucose levels
linked to a heightened risk of death (BBC, UK) |
| |
|
|
Novo
Nordisk gets US approval for Victoza but with warning |
| |
At long last, Novo Nordisk has been given regulatory
approval across the Atlantic for its diabetes drug Victoza (PharmaTimes) |
| |
|
|
New
drug for diabetics could end ordeal of daily insulin jabs |
| |
It is an oral form of Victoza, a medicine already
approved for use in diabetes ... Novo Nordisk, the company that
makes the drug, has turned it into a pill and is recruiting 155
patients in Britain to try it out in a trial, which is expected
to last a year (Daily Mail, UK) |
| |
|
|
Alizé Pharma
Signs Research Collaboration and License Option Agreement With
Lilly |
| |
Companies to collaborate on an exclusive basis
on Alizé Pharma's unacylated ghrelin (AZP-01) program for the treatment of Type II diabetes
(PharmaLive) |
| |
|
|
Phase
2 Trial of LX4211 Demonstrates Significant and Rapid Improvements
in Multiple Parameters in Type 2 Diabetic Patients |
| |
Significant Improvements in Glycemic Control
- Significant Reduction in HbA1c within Four Weeks - Favorable
Safety, Cardiovascular and Metabolic Profile Observed (PharmaLive) |
| |
|
|
The
dual-wave bolus feature in type 1 diabetes adult users of insulin
pumps |
| |
We assessed the effectiveness of DWB in 56 adult
patients with type 1 diabetes (T1DM) who were on continuous subcutaneous
insulin infusion via insulin pump for at least 2 years (Acta Diabetologica) |
| |
|
|
One
in every five hospital patients battling diabetes |
| |
Professor Anthony Barnett, clinical director
for diabetes at Heart of England NHS foundation trust, blamed unhealthy
lifestyles for the sharp increase [Daily Mail, UK] |
| |
|
|
Beta
cells need key protein to divide and conquer diabetes |
| |
Cyclin D2 is a member of a small family of proteins
that aid in the cell cycle, by which cells divide into two. Earlier
studies had demonstrated that cyclin D2 is particularly important
to the replication of beta cells but had not directly addressed
its role in insulin resistance (Joslin Diabetes Center) |
| |
|
|
Therapeutic
Options for Diabetic Foot Infections |
| |
This article reviews the commonly used therapeutic
options for treatment, including many newer antibiotics developed
to target multidrug-resistant gram-positive bacteria, and includes
available data relating specifically to the tissue penetration
of these agents (Journal of the American Podiatric Medical Association) |
| |
|
|
Attainment
of Canadian Diabetes Association recommended targets in patients
with type 2 diabetes |
| |
In this paper, which reports on parts 1 and
2 of our study, we document physicians’ knowledge of the CDA recommended targets for HbA1c, BP, and LDL-C in the province
of Newfoundland and Labrador, and the degree to which these targets
were achieved in 8 family practices in St John’s, Nfld (Canadian Family Physician) |
| |
|
|
Diabetes
and Dietary Supplements |
| |
It is important for health care practitioners
not only to be aware of what dietary supplements their patients
are taking, but also to understand how these supplements work and
their possible side effects (Clinical Diabetes) |
| |
|
|
Microparticle
levels may be an indicator of vascular dysfunction in diabetes
patients |
| |
The study results showed that the levels of
circulating MP, particularly EMP, may be an important indicator
of vascular dysfunction (ADA) |
| |
|
